arrow
Back
N

Neurocrine Biosciences

Scholars289
Papers103
Citations0
Related Papers (103)
Publication Date
F39. THE PATIENT-REPORTED TARDIVE DYSKINESIA IMPACT SCALE (TDIS) IN PATIENTS ≥65 YEARS TREATED WITH ONCE-DAILY VALBENAZINE: FINDINGS FROM KINECT-PRO™
err2026-08-14
err0
PREAI
errM. Mercedes Perez-Rodriguez; Joseph McEvoy; Ashok Parameswaran; Morgan Bron; Sara Gao; Sharon Cahoon-Metzger; Christine Holman; Susan D. Mathias; Gustavo Alva; Christoph U. Correll
errShare
errSave
Linking clinical trial data with real-world data for enhanced clinical evidence generation: methodological considerations and recommendations
err2026-08-14
err0
errOAAI
errAM Anna-Katharina Meinecke †; JD John Diaz-Decaro †; KM Kathleen M. Gavin; TS Tianyu Sun; JB Jordan B. Strom; MS Montse Soriano Gabarró; HL Hu Li; DY Dana Y. Teltsch; MN Mehdi Najafzadeh; CA Catherine A. Panozzo; PV Pareen Vora; MB Mehmet Burcu †
errShare
errSave
Glucocorticoid Reduction After Starting Crinecerfont in Pediatric Patients With Classic CAH: Practical Perspectives
err2026-05-04
err0
errOAAI
errNatalie J Nokoff; Patricia Y Fechner; Mimi S Kim; Ian Marshall; Deborah P Merke; Kyriakie Sarafoglou; Andrea L Hartzell; Vivian H Lin; Paul Thornton
errShare
errSave
Effectiveness and safety of implantable vagus nerve stimulation in people with primary generalized tonic-clonic seizures
err2026-05-01
err0
errOAAI
errEggleston, Katherine; Curley, Justine; Verner, Ryan; Dibue, Maxine; Gordon, Charles; Giannicola, Gaia; Nichol, Kathryn
errShare
errSave
Opicapone Improves the Pharmacokinetics of Levodopa Administered as Extended-Release Capsules
err2026-05-01
err0
PREAI
errLeWitt, Peter A.; Klepitskaya, Olga; Olson, Kurt; Liang, Grace; Loewen, Gordon
errShare
errSave
Opicapone in Parkinson's patients with motor fluctuations: clinical assessments and patient-reported outcomes from the OPTI-ON study
err2026-04-01
err0
PREAI
errKlepitskaya, Olga; LeWitt, Peter A.; Kilbane, Camilla; Seeberger, Lauren C.; Isaacson, Stuart H.; Gil, Ramon; Drake, Ryan S.; Kleiner, Galit; Stebbins, Glenn T.; Serbin, Michael; Brigas, Helena C.; Ramos, Daniel; Rattana, Stacy; Trotter, Jeff; Liang, Grace
errShare
errSave
Use of new approach methodologies (NAMs) in epilepsy research and seizure risk assessment
err2025-12-03
err0
errOAAI
errRuth A. Roberts; Mamta Behl; Helena T. Hogberg; Eduardo Dunayevich; Micheal Morton; Kimberly Rockley; Abigail L Walker; Jennifer Pierson
errShare
errSave
Efficacy and safety of iclepertin for cognitive impairment associated with schizophrenia (CONNEX programme): results from three phase 3 randomised controlled trials
err2025-11-11
err0
PREAI
errRichard S E Keefe; Philip D Harvey; Christoph U Correll; Peter Falkai; Naoki Hashimoto; Hans Klein; John H Krystal; Stephen Marder; Alice Medalia; Tomiki Sumiyoshi; Gang Wang; Hongyan Zhang; Zuzana Blahova; Ingrid Bichard-Sall; Brett A English; Eric Fu; Fredrik Gruenenfelder; Martina Groeschl; Karen Kimura; Wenbo Tang; Christoph von der Goltz; Corey Fowler
errShare
errSave
Valbenazine Sprinkle: An Alternative Formulation of Valbenazine for Oral Administration in Patients With Dysphagia
err2025-11-10
err0
errOAAI
errGiri, Nagdeep; Jimenez, Roland; Rees, Linda; Mar, Alexander; Bristow, Ali; Hebert, Mello; Maynard-scott, Jessica; Zhang, Hui; Brar, Satjit
errShare
errSave
Utility and limitations of the FDA adverse events reporting system public dashboard for safety analyses: a case study with vesicular monoamine transporter 2 inhibitors
err2025-11-01
err0
PREAI
errMcIntyre, Roger S.; Karpuram, Shree; Farahmand, Khodayar; Aldrich, Kira; Bron, Morgan; Vanderhoef, Dawn; Thomas, Nina; Jacobs, Michelle; Thai-Cuarto, Dao
errShare
errSave
VMAT2 inhibitors for the treatment of tardive dyskinesia: a narrative review
err2025-10-22
err0
errOAAI
errPatel, Amita R.; Hauser, Robert A.; Citrome, Leslie; Bahroo, Laxman; Hicks, Tracy; Maness, Alta; Farahmand, Khodayar; Aldrich, Kira; Vanderhoef, Dawn; Cutler, Andrew J.
errShare
errSave
errShare
errSave
De-risking seizure liability: integrating adverse outcome pathways (AOPs), new approach methodologies (NAMs), and in silico approaches while highlighting knowledge gaps
err2025-08-01
err0
PREAI
errBehl, Mamta; Karmaus, Agnes; Rao, Mohan; Lane, Thomas; Harris, Joshua; Sachs, Clifford; Borrel, Alexandre; Oyetade, Oluwakemi; Unnikrishnan, Aswani; Hamm, Jonathan; Hogberg, Helena T.
errShare
errSave
Reimagining Advanced Chemistry Education: A Community-based Approach to Course Design for Modern Learners
err2025-08-01
err0
PREAI
errHorwitz, Matthew A.; Al-Ahmad, Reem; Bai, Xingfeng; Balletti, Matteo; Bellotti, Peter; Ben-Tal, Yael; Campbell, Mark W.; Cheasty, Kathleen; Crossley, Steven W. M.; Day, Craig S.; Deneny, Patrick J.; Forbes, Katherine C.; Gogarnoiu, Emma S.; Grant, Phillip S.; Halder, Riya; Harris, Georgia R.; Hernandez-Llado, Pol; Jouanneau, Morgan; Jost, Vera; Kutateladze, Dennis A.; Laudadio, Gabriele; Liu, Chun; Looby, Aidan P.; Maestro, Aitor; Mccallum, Terry; Palkowitz, Maximilian D.; Paolillo, Joshua M.; Perry, Matthew W. D.; Reisenbauer, Julia C.; Reyes, Cesar; Sharma, Hayden A.; Sheong, Fu Kit; Thoma, Benjamin; Tran, Andrew V.; Tran, Duc N.; Aguilar Troyano, Francisco Jose; Verheyen, Thomas; Walsh, Mark P.; Wagner, Alicia; Wearing, Emily R.; Wuitschik, Georg
errShare
errSave
Green Chemistry Articles of Interest to the Pharmaceutical Industry
err2025-05-10
err0
PREAI
errAshley, Melissa A.; Aukland, Miles H.; Bryan, Marian C.; Cismesia, Megan A.; Dutschei, Theresa; Engl, Oliver D.; Engl, Pascal S.; Garcia, Alvaro Enriquez; Molina, Alejandro Gimenez; Harawa, Vanessa; Karageorgis, George; Keily, Shazia; Kelly, Christopher B.; Leclair, Alexandre; Lee, Johnny W.; Li, Wei; Osborne, Matthew; Pawlas, Jan; Richardson, Paul F.; Scott, Samuel C.; Steven, Alan; Takale, Balaram S.; Zeng, Mingshuo
errShare
errSave
Differences in resting state and task-based EEG measures between patients with major depressive disorder and healthy controls
err2025-05-01
err0
errOAAI
errKovacevic, Natasha; Meghdadi, Amir; Berka, Chris; Saad, Ziad S.; Kolb, Hartmuth C.; de Boer, Peter; Furey, Maura; Miller, Silke
errShare
errSave
Towards Enhancing Drug Development Methodology to Treat Cognitive Impairment Associated With Schizophrenia and Other Neuropsychiatric Conditions: Insights From 2 Decades of Clinical Trials
err2025-02-21
err0
errOAAI
errHoran, William P.; Kalali, Amir; Brannan, Stephen K.; Drevets, Wayne; Leoni, Matthew; Mahableshwarkar, Atul; Martin, William J.; Rao, Srinivas; Reuteman-Fowler, Corey; Sauder, Colin; Savitz, Adam; Singh, Jaskaran; Tiller, Jane; Walker, Gary; Wendland, Jens R.; Harvey, Philip D.
errShare
errSave